Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Invitae Hereditary Cerebral Small Vessel Disease Panel Invitae United States | 24 | 10 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Myofibromatosis, infantile 2, 615293, Autosomal dominant (Infantile myofibromatosis) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Infantile Myofibromatosis Panel PreventionGenetics, part of Exact Sciences United States | 2 | 2 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Leukodystrophy and leukoencephalopathy panel. NGS panel of 74 genes. Genologica Medica Spain | 96 | 74 |
|
Migraine panel. NGS panel of 10 genes. Genologica Medica Spain | 30 | 10 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Genologica Medica Spain | 6 | 2 |
|
Asper Biogene Asper Biogene LLC Estonia | 28 | 13 |
|
Infantile myofibromatosis: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 2 |
|
Adolescent/Adult Epilepsy NGS Panel Fulgent Genetics United States | 182 | 82 |
|
Lateral Meningocele Syndrome (NOTCH3 Single Gene Test) Fulgent Genetics United States | 2 | 1 |
|
CADASIL (NOTCH3 Single Gene Test) Fulgent Genetics United States | 2 | 1 |
|
Hypomyelinating Leukodystrophy NGS Panel Fulgent Genetics United States | 225 | 62 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.